Ident. | Authors (with country if any) | Title |
---|
001337 |
Elan D. Louis [États-Unis] ; Kathryn M. Pellegrino [États-Unis] ; Pam Factor-Litvak [États-Unis] ; Eileen Rios [États-Unis] ; Wendy Jiang [États-Unis] ; Claire Henchcliffe [États-Unis] ; WEI ZHENG [États-Unis] | Cancer and Blood Concentrations of the Comutagen Harmane in Essential Tremor |
001343 |
Eric J. Pappert [États-Unis] ; Terry Germanson [Canada] | Botulinum Toxin Type B vs. Type A in Toxin-Naïve Patients with Cervical Dystonia : Randomized, Double-Blind, Noninferiority Trial |
001921 |
Nam-Jong Paik [Corée du Sud] ; Kyle Seo [Corée du Sud] ; HEE CHUL EUN [Corée du Sud] | Reduced potency after refrigerated storage of botulitum toxin A : Human extensor digitorum brevis muscle study |
001C16 |
Danella Hafeman [États-Unis] ; Habibul Ahsan [États-Unis] ; Tariqul Islam [Bangladesh] ; Elan Louis [États-Unis] | Betel quid : Its tremor-producing effects in residents of araihazar, bangladesh |
002139 |
Frank J. Erbguth [Allemagne] | Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin |
002282 |
Alberto J. Espay [Canada] ; Peter Ashby [Canada] ; Ritsuko Hanajima [Canada] ; Mandar S. Jog [Canada] ; Anthony E. Lang [Canada] | Unique form of propriospinal myoclonus as a possible complication of an enteropathogenic toxin |
002528 |
Brad A. Racette [États-Unis] ; Laura Good [États-Unis] ; Sandy Sagitto [États-Unis] ; Joel S. Perlmutter [États-Unis] | Botulinum toxin B reduces sialorrhea in parkinsonism |
002662 |
Alfredo Berardelli [Italie] ; Antonio Curra [Italie] | Pathophysiology and treatment of cranial dystonia |
002842 |
Dirk Dressler [Royaume-Uni] ; Hans Bigalke [Allemagne] | Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy |
002843 |
C. Detrembleur [Belgique] ; T. M. Lejeune [Belgique] ; A. Renders [Belgique] ; P. Y. K. Van Den Bergh [Belgique] | Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy |
002882 |
Carla Cordivari [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of dystonic clenched fist with botulinum toxin |
002904 |
S. Thobois [France] ; E. Broussolle [France] ; L. Toureille [France] ; C. Vial [France] | Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy |
002955 |
R. Richard Sloop [États-Unis] ; Dorothee Cole [États-Unis] ; Milan C. Patel [États-Unis] | Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals |
002A04 |
Elan D. Louis [États-Unis] | Etiology of essential tremor: Should we be searching for environmental causes? |
002A15 |
Jorg Müller [Autriche] ; Georg Ebersbach [Autriche] ; Jorg Wissel [Autriche] ; Werner Poewe [Autriche] | Dynamic balance function in phasic cervical dystonia following Botulinum toxin therapy |
002A44 |
JINWHAN CHO [Corée du Sud] ; KON CHU [Corée du Sud] ; Beom S. Jeon [Corée du Sud] | Case of essential palatal tremor: Atypical features and remarkable benefit from botulinum toxin injection |
002A76 |
| Abstracts from International Conference 1999: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Orlando, FL, USA, November 16-18, 1999 |
002A88 |
D. Dressler [Allemagne] ; M. Wittstock [Allemagne] ; R. Benecke [Allemagne] | Treatment of persistent hemiballism with botulinum toxin type A |
002B12 |
F. Birklein [Allemagne] ; F. Erbguth [Allemagne] | Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A : A preliminary observation |
002B47 |
A. Brashear [États-Unis] ; K. Bergan [États-Unis] ; J. Wojcieszek [États-Unis] ; E. R. Siemers [États-Unis] ; W. Ambrosius [États-Unis] | Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A |
002C04 |
Francisco Cardoso [Brésil] ; José Teotonio De Oliveira [Brésil] ; Marzia Puccioni-Sohler [Brésil] ; Alexandre R. Fernandes [Brésil] ; James Pitagoras De Mattos [Brésil] ; Iscia Lopes-Cendes [Brésil] | Eyelid dystonia in Machado-Joseph disease |
002C25 |
S. Palfi [États-Unis] ; L. Leventhal [États-Unis] ; C. G. Goetz [États-Unis] ; P. Hantraye [France] ; B.-Z. Roitberg [États-Unis] ; J. Sramek [États-Unis] ; M. Emborg [États-Unis] ; J. H. Kordower [États-Unis] | Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys |
002C42 |
Dirk Dressler [Allemagne] ; Uwe Zettl [Allemagne] ; Reiner Benecke [Allemagne] ; Hans Bigalke [Allemagne] | Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure? |
002C46 |
A. Rapaport [Israël] ; M. Sadeh [Israël] ; D. Stein [Israël] ; J. Levine [Israël] ; P. Sirota [Israël] ; T. Mosheva [Israël] ; S. Stir [Israël] ; A. Elitzur [Israël] ; I. Reznik [Israël] ; D. Geva [Israël] ; J. M. Rabev [Israël] | Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia |
002C47 |
D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay |
002C96 |
P. Kanovsky [République tchèque] ; H. Streitova [République tchèque] ; M. Bares [République tchèque] ; H. Hortova [République tchèque] | Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A : Evidence of a long-lasting effect |
002D14 |
A. Lagueny [France] ; F. Tison [France] ; P. Burbaud [France] ; G. Le Masson [France] ; P. Kien [France] | Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A |
002D16 |
M. S. Moreau [France] ; A. Severac Cauquil [France] ; M. C. Costes Salon [France] | Static and dynamic balance function in spasmodic torticollis |
002D67 |
D. Tarsy [États-Unis] ; E. R. First [États-Unis] | Painful cervical dystonia : Clinical features and response to treatment with botulinum toxin |
002E26 |
R. Chen [États-Unis, Canada] ; B. I. Karp [États-Unis] ; S. R. Goldstein [États-Unis] ; W. Bara-Jimenez [États-Unis] ; Z. Yaseen [États-Unis] ; M. Hallett [États-Unis] | Effect of muscle activity immediately after botulinum toxin injection for writer's cramp |
002E46 |
T. Mezaki [Japon] ; R. Kaji [Japon] ; M. F. Brin [États-Unis] ; M. Hirota-Katayama [Japon] ; T. Kubori [Japon] ; T. Shimizu [Japon] ; J. Kimura [Japon] | Combined use of type A and F botulinum toxins for blepharospasm : A double-blind controlled trial |
002E95 |
M. R. Trimble [Royaume-Uni] ; R. Whurr [Royaume-Uni] ; G. Brookes [Royaume-Uni] ; M. M. Robertson [Royaume-Uni] | Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections |
002E97 |
C. Sankhla [États-Unis] ; Joseph Jankovic [États-Unis] ; D. Duane [États-Unis] | Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections |
002F04 |
M. Bakar [Turquie] ; M. Zarifoglu [Turquie] ; I. Bora [Turquie] ; F. Turan [Turquie] ; C. Sen [Turquie] ; E. Ogul [Turquie] | Treatment of hereditary trembling chin with botulinum toxin |
002F05 |
R. Lindeboom [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; M. Aramideh [Pays-Bas] ; H. D. Speelman [Pays-Bas] ; R. J. De Haan [Pays-Bas] | Treatment of cervical dystonia : A comparison of measures for outcome assessment |
003021 |
C. L. Comella [États-Unis] ; K. M. Shannon [États-Unis] ; J. Jaglin [États-Unis] | Extensor truncal dystonia : Successful treatment with botulinum toxin injections |
003029 |
C. M. Gudex [Danemark] ; M. R. Hawthorne [Royaume-Uni] ; A. G. Butler [Royaume-Uni] ; P. Duffey [Royaume-Uni] | Effect of dystonia and botulinum toxin treatment on health-related quality of life |
003055 |
A. Brashear [États-Unis] ; W. T. Ambrosius [États-Unis] ; G. J. Eckert [États-Unis] ; E. R. Siemers [États-Unis] | Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A |
003067 |
P. Katlovsky [République tchèque] ; H. Streitova [République tchèque] ; J. Dufek [République tchèque] ; V. Znojil [République tchèque] ; P. Daniel [République tchèque] ; I. Rektor [République tchèque] | Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A |
003120 |
R. Eleopra [Italie] ; V. Tugnoli [Italie] ; D. De Grandis [Italie] | The variability in the clinical effect induced by botulinum toxin type A : The role of muscle activity in humans |
003134 |
K. R. Kessler [Allemagne] ; R. Benecke [Allemagne] | The EDB test : A clinical test for the detection of antibodies to botulinum toxin type A |
003156 |
A. Albanese ; G. Maria [Italie] ; A. Bentivoglio ; T. Brisinda [Italie] ; E. Cassetta [Italie] ; P. Tonali | Severe constipation in Parkinson's disease relieved by botulinum toxin |
003166 |
J. Wissel [Allemagne, Autriche] ; F. Masuhr [Allemagne] ; L. Schelosky [Allemagne] ; G. Ebersbach [Allemagne, Autriche] ; Werner Poewe [Autriche] | Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor |
003217 |
P. A. Lewitt [États-Unis] ; R. M. Trosch [États-Unis] | Idiosyncratic adverse reactions to intramuscular botulinum toxin type a injection |
003246 |
C. Sampaio [Portugal] ; J. J. Ferreira [Portugal] ; F. Simoes [Portugal] ; M. J. Rosas [Portugal] ; M. Magalhaes [Portugal] ; A. P. Correia [Portugal] ; A. Bastos-Lima [Portugal] ; R. Martins [Portugal] ; A. Castro-Caldas [Portugal] | DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1 |
003255 |
D. Tarsy [États-Unis] | Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin |
003271 |
N. Giladi [Israël] ; S. Honigman [Israël] | Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease |
003272 |
R. Liguori [Italie] ; C. Cordivari [Italie] ; E. Lugaresi [Italie] ; P. Montagna [Italie] | Botulinum toxin a improves muscle spasms and rigidity in Stiff-Person syndrome |
003273 |
D. D. Truong [États-Unis] ; P. A. Cullis [États-Unis] ; C. F. O'Brien [États-Unis] ; M. Koller [États-Unis] ; T. P. Villegas [États-Unis] ; J. D. Wallace [États-Unis] | BotB (botulinum toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study) |
003304 |
P. Girlanda [Italie] ; A. Quartarone ; S. Sinicropi ; C. Nicolosi ; C. Massina | Unilateral injection of botulinum toxin in blepharospasm : single fiber electromyography and blink reflex study |
003308 |
R. Lindeboom [Pays-Bas] ; R. J. De Haan ; M. Aramideh [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; J. D. Speelman [Pays-Bas] | Treatment outcomes in cervical dystonia : A clinimetric study |
003310 |
J. A. Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of nonoccupational limb and trunk dystonia with botulinum toxin |
003325 |
P. E. Greene [États-Unis] ; S. Fahn [États-Unis] | Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients |
003338 |
C. H. Adler [États-Unis] ; R. S. Zimmerman ; M. K. Lyons ; F. Simeone ; M. F. Brin | Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease |
003401 |
G. W. Paulson [États-Unis] ; W. Gill [États-Unis] | Botulinum toxin is unsatisfactory therapy for fibromyalgia |
003402 |
B. L. Scott [États-Unis] ; Joseph Jankovic [États-Unis] ; D. T. Donovan | Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome |
003403 |
S. Salloway [États-Unis] ; C. F. Stewart [États-Unis] ; L. Israeli ; X. Morales ; S. Resmussen [États-Unis] ; A. Blitzer [États-Unis] ; M. F. Brin [États-Unis] | Botulinum toxin for refractory vocal tics |
003420 |
Joseph Jankovic [États-Unis] ; K. Schwartz [États-Unis] ; W. Clemence [États-Unis] ; A. Aswad ; J. Mordaunt | A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor |
003436 |
R. Lindeboom [Pays-Bas] ; R. De Haan ; M. Aramideh ; J. D. Speelman | The blepharospasm disability scale : an instrument for the assessment of functional health in blepharospasm |
003492 |
G. Ebersbach [Allemagne] ; C. Kabus ; L. Schelosky [Allemagne] ; L. Terstegge ; Werner Poewe [Allemagne] | Hemimasticatory spasm in hemifacial atrophy : diagnostic and therapeutic aspects in two patients |
003505 |
R. Cole [États-Unis] ; M. Hallett ; L. G. Cohen | Double-blind trial of botulinum toxin for treatment of focal hand dystonia |
003516 |
D. Claus [Allemagne] ; A. Druschky ; F. Erbguth | Botulinum toxin : influence on respiratory heart rate variation |
003517 |
D. Tarsy [États-Unis] ; S. C. Schachter | Botulinum toxin treatmenty is not effective for epilepsy partialis continua |
003524 |
N. J. Scolding [Royaume-Uni] ; S. M. Smith [Royaume-Uni] ; S. Sturman ; G. B. Brookes [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Auctioneer's jaw : a case of occupational oromandibular hemidystonia |
003543 |
C. Pacchetti [Italie] ; G. Albani ; E. Martignoni ; L. Godi ; E. Alfonsi ; G. Nappi | "Off" painful dystonia in Parkinson's disease treated with botulinum toxin |
003546 |
| |
003600 |
M. Merello [Argentine] ; H. Garcia ; M. Nogues ; R. Leiguarda | Masticatory muscle spasms in a non-japanese patient with satoyoshi syndrome successfully treated with botulinum toxin |
003610 |
G. E. Borodic [États-Unis] ; R. Ferrante ; L. Bruce Pearce ; K. Smith [États-Unis] | Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections |
003623 |
K. B. Polo [États-Unis] ; BAHMAN JABBARI | Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin |
003628 |
P. Greene [États-Unis] ; S. Fahn [États-Unis] ; B. Diamond | Development of resistance to botulinum toxin type A in patients with torticollis |
003637 |
Joseph Jankovic [États-Unis] | Botulinum toxin in the treatment of dystonic tics |
003638 |
R. M. Trosch [États-Unis] ; S. L. Pullman | Botulinum toxin A injections for the treatment of hand tremors |
003650 |
P. Krack [Allemagne] ; M. H. Marion | "apraxia of lid opening," a focal eyelid dystonia : clinical study of 32 patients |
003654 |
| |
003658 |
P. E. Greene [États-Unis] ; S. Fahn | Use of botulinum toxin Type F injections to treat torticollis in patients with immunity to Botulinum toxin Type A |
003663 |
C. G. Garner [Allemagne] ; A. Straube ; T. N. Witt ; T. Gasser ; W. H. Oertel | Time course of distant effects of local injections of botulinum toxin |
003681 |
D. Davis [États-Unis] ; B. Jabbari | Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A |
003691 |
D. Dykstra [États-Unis] ; C. Ellingham ; A. Belfie ; T. Baxter ; M. Lee ; A. Voelker | Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin |
003696 |
A. Feve [France] ; B. Angelard [France] ; G. Fenelon [France] ; M. Logak [France] ; A. Guillard [France] ; J. Lacau Saint-Guily | Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin |
003840 |
J. Rivest ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden | Writer's cramp : treatment with botulinum toxin injections |
003847 |
I. T. Lorentz [Australie] ; S. Shanthi Subramaniam ; C. Yiannikas | Treatment of idiopathic spasmodic torticollis with botulinum toxin A : a double-blind study on twenty-three patients |
003A19 |
M. F. Brin ; A. Blitzer ; S. Fahn ; W. Gould ; R. E. Lovelace | Adductor laryngeal dystonia (Spastic dysphonia): treatment with local injections of botulinum toxoin (Botox) |
003A33 |
A. B. Scott ; D. Suzuki | Systemic toxicity of botulinum toxin by intramuscular injection in the monkey |
003A76 |
M. F. Brin ; S. Fahn ; C. Moskowitz ; A. Friedman ; H. M. Shale ; P. E. Greene ; A. Blitzer ; T. List ; D. Lange ; R. E. Lovelace ; D. Mcmahon | Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm |